Many people worry: “Will Mounjaro’s side effects stay with me in the future?” “Is it okay to keep using it for more than a year?” “Will stopping it harm my body?” In short, at present there are no symptoms for which a causal link to permanent lasting effects has been established, but there is also not enough data to say for certain that it is safe over 10 or 20 years.
In this article, based on the electronic package insert and RMP from the PMDA (Pharmaceuticals and Medical Devices Agency) as of May 2026, the 3-year SURMOUNT-1 trial, and the SURMOUNT-4 trial, which looked at stopping treatment, we summarize what is known about future side effects, lasting effects, and changes after stopping Mounjaro (generic name: tirzepatide).
Key points firstBusy? Just read this part
- At present, no causal link has been established showing that Mounjaro leaves permanent lasting effects in humans.
- On the other hand, the available clinical trials last a few years at most, and very long-term effects 10 or 20 years later are not yet known.
- Side effects such as nausea, diarrhea and constipation tend to occur when starting treatment or increasing the dose. Severe abdominal pain, repeated vomiting, jaundice, difficulty breathing and similar symptoms require prompt medical attention.
- It has not been confirmed that the drug leaves lasting effects on the body after stopping, but your appetite and weight may come back. Don’t stop on your own—make a plan with your doctor for maintaining your weight after weight loss.
Do Mounjaro side effects last? What is known and what is not
Clinical trials lasting a few years have not identified any new safety signals, but very long-term effects remain uncertain. It is not appropriate to state flatly either that “there are definitely no lasting effects” or that “long-term use is dangerous.”
| What is known at present |
|---|
| Gastrointestinal symptoms such as nausea, diarrhea and constipation are relatively common and tend to occur when starting treatment or increasing the dose |
| There are risks that are not common but can become serious, such as acute pancreatitis, biliary disease, bowel obstruction (ileus) and severe allergic reactions |
| A 176-week trial in participants with obesity and prediabetes identified no new safety signals |
| Weight tends to come back after stopping |
| What is not yet known |
|---|
| Safety when used over 10 or 20 years |
| To what extent the thyroid C-cell tumors seen in animal studies represent a risk in humans |
| Very long-term safety in healthy people using it for cosmetic purposes, and in Japanese people |
| Who is more likely to maintain their weight after stopping, and the best way to end treatment |
In the PMDA Risk Management Plan (RMP), hypoglycemia and acute pancreatitis are monitored as “important identified risks,” and thyroid C-cell tumors, pancreatic cancer, acute biliary disease, bowel obstruction (ileus), anaphylaxis and angioedema, among others, as “important potential risks.” A potential risk does not mean “a causal link has been confirmed”; it means a risk for which information needs to continue to be collected.
Is it okay to use Mounjaro for more than a year? Results of long-term trials
Continuing treatment assumes that a doctor checks whether it is appropriate for you and how you are doing, and monitors side effects. There is no rule that “it becomes dangerous across the board after 1 year.” However, being able to use it long term is not the same as saying everyone should use it long term.
| Trial | Participants and duration | Findings | Caveats for interpretation |
|---|---|---|---|
| SURMOUNT-1 long-term analysis | Participants with obesity and prediabetes; 176 weeks + 17 weeks after stopping | In the treatment groups, mean weight change at 176 weeks was −12.3% to −19.7% depending on dose. Most gastrointestinal symptoms were mild to moderate and occurred mainly during the dose escalation phase in the first 20 weeks. No new safety signals were identified | Results from trial participants with prediabetes; safety over 10 or 20 years is not known |
| SURMOUNT-4 | Participants with obesity or overweight; 88 weeks in total | The group switched to placebo after 36 weeks regained an average of 14.0% of body weight over the following 52 weeks. The group that continued lost an average of a further 5.5% | This trial does not show that stopping causes “lasting effects”; it shows how likely weight regain is |
| SURPASS-CVOT | 13,165 patients with type 2 diabetes and atherosclerotic cardiovascular disease | Non-inferiority to dulaglutide was confirmed on a composite of cardiovascular death, myocardial infarction and stroke | Superiority was not shown, and the results cannot be applied directly to healthy people seeking weight loss |
Key point
Long-term data are increasing, but you cannot say “there were no problems for 3 years, so it will definitely be safe in the future.” It is important to keep checking your medical history, other medications, the speed of weight loss and your nutritional status from before you start.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
When should you be careful? The typical course of common side effects
Gastrointestinal symptoms such as nausea, diarrhea, constipation, vomiting and abdominal discomfort tend to occur right after starting treatment or after a dose increase. In long-term trials, too, most gastrointestinal symptoms were seen during the dose escalation phase. However, it is dangerous to keep putting up with symptoms, assuming “they will definitely go away with time.”
| Symptoms and course | Basic response |
|---|---|
| Mild nausea, constipation, diarrhea, abdominal discomfort | Don’t eat large amounts at once and avoid fatty meals. If symptoms continue, consult your prescribing doctor without waiting for your next dose |
| Unable to keep fluids down, repeated vomiting, passing little urine | Contact a medical institution promptly, as there is a risk of dehydration and worsening kidney function |
| Severe or persistent upper abdominal pain, pain radiating to the back | Stop the medication and see a doctor promptly, as this may be acute pancreatitis |
| Upper right abdominal pain, fever, jaundice | See a doctor, as this may be gallstones, cholecystitis or a similar condition |
| Severe constipation, abdominal bloating, vomiting, unable to pass stool or gas | See a doctor promptly, as this may be bowel obstruction (ileus) |
Side effects and lasting effects people worry about, explained one by one
Does it strain the pancreas? The link with acute pancreatitis and pancreatic cancer
Acute pancreatitis is a serious adverse reaction that the electronic package insert and RMP warn about. If you have persistent severe abdominal pain, do not wait until your next appointment. On the other hand, pancreatic cancer is a “potential risk” in the RMP, and it has not been established that Mounjaro causes pancreatic cancer in humans. If you have a history of pancreatitis, be sure to tell your doctor before starting.
Could it cause thyroid cancer?
An increase in thyroid C-cell tumors was seen in studies in rats, but the effect in humans is unknown. There is no evidence that “you will definitely get thyroid cancer in the future.” If you have a persistent lump in your neck, hoarseness or difficulty swallowing, consult your doctor. This does not mean everyone needs a calcitonin test or thyroid ultrasound; whether testing is needed is decided based on your medical history and symptoms.
Can Mounjaro cause depression? The link with psychiatric symptoms
In January 2026, the US FDA comprehensively evaluated GLP-1 receptor agonists and announced that no increased risk of suicidal thoughts or suicidal behavior was found. There is no evidence to state definitively that Mounjaro causes depression. However, other factors are possible, such as undernutrition during weight loss, feeling physically unwell, or a pre-existing mental health condition. If you notice changes such as low mood, insomnia, severe anxiety or thoughts of self-harm, don’t try to judge for yourself whether they are related to the medication—consult a medical institution right away.
Will hair loss or thinning hair last into the future?
When you lose a lot of weight in a short time, hair loss may increase due to factors such as poor nutrition and physical stress. It has not been confirmed that tirzepatide permanently damages hair roots, but if hair loss continues, it needs to be assessed, including the speed of weight loss, your intake of nutrients such as protein and iron, thyroid function, and other diseases and medications. Consult your doctor before taking large amounts of supplements on your own.
Can loss of muscle mass be a lasting effect?
When you lose weight, you may lose not only fat but also lean body mass. Lean body mass does not mean muscle alone, but you need to watch for loss of muscle strength in situations such as eating extremely little, losing weight rapidly, or not doing strength exercise. Check not only your weight but also how much you eat, your activity level and your muscle strength, and if your health is stable, include reasonable strength training.
What about pregnancy and future pregnancy?
If you are pregnant, may be pregnant, wish to become pregnant, or are breastfeeding, be sure to tell your doctor before starting or as soon as you find out. There are not enough safety data on use during pregnancy in humans. Future infertility has not been confirmed, but avoid both continuing on your own judgment because “I want to get pregnant later, so it’s fine” and stopping suddenly “because I’m worried”—discuss a plan with your prescribing doctor.
Can Mounjaro side effects be fatal?
It is not possible to say simply that “using Mounjaro causes death.” On the other hand, conditions such as acute pancreatitis, severe hypoglycemia, anaphylaxis, bowel obstruction (ileus) and worsening kidney function due to dehydration can become serious if left untreated. It is important not to use personally imported medication or medication obtained from someone else, and not to put up with severe symptoms.
What happens after stopping Mounjaro? Rebound weight gain is not a lasting side effect
After stopping the medication, your appetite may return and you may regain weight. In SURMOUNT-4, the group switched to placebo after 36 weeks of treatment regained an average of 14.0% of body weight over the following 52 weeks. Rather than a “lasting effect” of the drug damaging the body, it is more appropriate to see this as the return of the appetite and weight regulation that the drug had been suppressing.
When considering stopping, check at least the following with your prescribing doctor:
- Your reason for stopping or adjusting the dose (side effects, reaching your goal, cost, wishing to become pregnant, etc.)
- Rules for meal portions and snacks if your appetite returns
- Weekly weight changes and when to come back for a visit
- How to maintain your weight, including protein intake, exercise and sleep
- If you are being treated for diabetes, adjustment of blood sugar and other medications
Reasons you may need to stop Mounjaro and symptoms to report right away
Whether to continue Mounjaro is not decided only by whether you are losing weight. In the following cases, contact your prescribing doctor before injecting your next dose on your own judgment.
- Severe abdominal pain, pain radiating to the back, or repeated vomiting
- Unable to keep fluids down, reduced urine output, or severe weakness
- Unable to pass stool or gas, with abdominal bloating and vomiting
- Rash, swelling of the face or throat, or difficulty breathing
- Cold sweats, palpitations, lightheadedness, or feeling dazed or confused
- Barely able to eat, continuing rapid weight loss, or a clear loss of muscle strength
- You find out you are pregnant, wish to become pregnant, or have surgery or a procedure involving sedation scheduled
Depending on how urgent the symptoms are, go to an emergency medical facility without waiting to contact your prescribing doctor.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Monitoring items to check during long-term use
Not everyone has the same tests at the same frequency. Your doctor decides based on your symptoms, whether you have diabetes, other medications, kidney function, medical history and so on.
| Item | Purpose |
|---|---|
| Weight, BMI, waist circumference, food intake, muscle strength and activity level | Check the speed of weight loss, undernutrition and loss of muscle strength |
| Nausea, vomiting, constipation, diarrhea, abdominal pain, jaundice | Check for signs of gastrointestinal disorders, dehydration, pancreatitis, biliary disease and bowel obstruction (ileus) |
| Blood sugar and HbA1c | Check treatment effect and hypoglycemia/hyperglycemia; especially important when taking diabetes medications |
| Kidney function, electrolytes, etc. | Assessed when dehydration or worsening kidney function due to vomiting or diarrhea is suspected |
| Eye symptoms | In people with diabetic retinopathy, watch for changes associated with rapid improvement in blood sugar |
| Mood, sleep and quality of life | Assessed taking into account not only the medication but also undernutrition, physical condition and past illnesses |
Key point
This does not mean that pancreatic enzymes, calcitonin, gallbladder ultrasound and so on are checked routinely and regularly in everyone without symptoms. Rather than adding unnecessary tests, it is important to choose the tests needed based on your symptoms and background.
In Japan, Mounjaro and Zepbound have different approved indications
Mounjaro and Zepbound both contain the active ingredient tirzepatide. However, in Japan, Mounjaro is approved for type 2 diabetes and Zepbound for obesity disease meeting certain criteria, among others, so the approved indications differ by brand name. “Same ingredient, same use” does not necessarily apply.
Using Mounjaro for weight loss is a use that differs from its approved indications in Japan, and it is self-pay treatment. Make your choice after receiving an explanation of whether the treatment is suitable for you, what effects can be expected, known side effects, alternative treatments and costs, and once you are satisfied.
About self-pay treatment and off-label use
FAQ
QIf I haven’t had any side effects from Mounjaro, will it be safe in the future too?
Having no side effects now is a good sign, but it does not guarantee future safety. Nor does having no side effects mean the medication isn’t working. Continue to see your doctor after dose increases and when your health changes.
QWill using Mounjaro cause diabetes in the future?
It has not been shown that Mounjaro causes diabetes in the future. In the 176-week SURMOUNT-1 long-term analysis in participants with obesity and prediabetes, type 2 diabetes developed in 1.3% of the treatment groups and 13.3% of the placebo group. However, these are trial results during treatment and do not show lifelong prevention after stopping.
QWill I build up a tolerance if I use it for more than a year?
A “plateau,” where weight loss slows down, can happen, but it does not immediately mean the medication has stopped working or become dangerous. We check your intake, activity level, target weight, dose and side effects, and review the treatment plan rather than assuming a dose increase.
QIs Mounjaro a medication I have to take for life?
Not everyone needs to take it for life. Diabetes and obesity disease may require chronic management, but how long to continue is decided individually based on effectiveness, side effects, goals, complications, cost and your own wishes. Rather than stopping suddenly on your own, discuss with your doctor, including a plan for maintaining your weight after treatment ends.
Not sure? Talk to us
No consultation fee (first & follow-up visits)Online consultation available
Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)
Summary | Because the future is uncertain, review your treatment regularly
At present, no causal link has been established showing that Mounjaro leaves permanent lasting effects in humans. A 3-year long-term trial identified no new safety signals, but there are no data that allow us to say for certain that it is safe 10 or 20 years ahead.
What matters is that people who need it use it under a doctor’s supervision, with checks for gastrointestinal symptoms, pancreatitis and biliary disease, bowel obstruction (ileus), hypoglycemia, allergies, dehydration, nutritional status and so on. Anticipate weight regain after stopping, and plan your diet, exercise and visits from the time you start the medication.
References and official sources
- Pharmaceuticals and Medical Devices Agency (PMDA): “Mounjaro Subcutaneous Injection Ateos – prescription drug information” (Japanese) (electronic package insert: May 19, 2026)
- PMDA: “Mounjaro / Zepbound Risk Management Plan (RMP)” (Japanese)
- Jastreboff AM, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025;392:958-971.
- Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity. JAMA. 2024;331(1):38-48.
- Nicholls SJ, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. N Engl J Med. 2025;393:2409-2420.
- U.S. Food and Drug Administration. FDA’s Evaluation Did Not Identify an Increased Risk of Suicidal Ideation or Behavior With GLP-1 RA Medications. 2026.
Who to contact if you have side effects | When to seek medical care
If you have any of the following symptoms, do not wait and see on your own—please contact us. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but in rare cases they can be serious.
| Symptom | Possible cause | What to do |
|---|---|---|
| Ongoing nausea or vomiting and unable to keep fluids down | Gastrointestinal disorder, dehydration, worsening kidney function | Contact us without waiting for your next dose |
| Severe abdominal pain (pain radiating to the back) | Possible acute pancreatitis | Stop the medication and see a doctor promptly |
| Upper right abdominal pain, fever, jaundice | Possible gallstones, cholecystitis or similar | See a doctor promptly |
| Severe abdominal bloating, vomiting, unable to pass stool or gas | Possible bowel obstruction (ileus) | See a doctor promptly |
| Cold sweats, palpitations, intense hunger, or feeling dazed or confused | Hypoglycemia | Take some sugar if you can and contact us. If consciousness is impaired, consider calling an ambulance |
| Rash, difficulty breathing, or swelling of the face or throat | Possible anaphylaxis or angioedema | Go to an emergency medical facility immediately |
If your symptoms are severe outside these hours, please go to your nearest emergency medical facility.
Direct phone numbers for each clinic are listed on the clinic information page.
*This article is intended to provide general information and is not a substitute for diagnosis or treatment. Effects and side effects vary from person to person. Always consult your doctor before starting, increasing or stopping the medication.







